A new technology under development by an academic–industry partnership protects oral vaccines from destruction by the digestive system. From the mouth to the small intestine, the digestive system presents a series of challenges designed to protect us by killing ingested bacteria.
Using advanced imaging techniques and cognitive tests that assessed memory, researchers have shown that soccer players who frequently head the ball have brain abnormalities resembling those found in patients with concussion (mild traumatic brain injury).
The national organization that manages organ transplants on Monday resisted making emergency rule changes for children under 12 who are waiting on lungs but created a special appeal and review system to hear such cases. The executive committee of the Organ Procurement and Transplantation Network...
Aveo Oncology said Monday that the Food and Drug Administration has refused to approve its cancer drug tivozanib, saying the clinical trial data supporting the drug was not clear. Aveo, whose formal name is Aveo Pharmaceuticals Inc., is seeking approval for tivozanib as a treatment for advanced...
Federal prosecutors in New Jersey say a former executive for biopharmaceuticals company Bristol-Myers Squibb has admitted using his high-level position and access to nonpublic information to make about $310,000 from insider trades. Robert Ramnarine pleaded guilty Monday to securities fraud. The...
At the 61st ASMS conference, Bruker introduced new High-Definition capabilities in proteomics and biomarker research. Patented low-noise Captivespray nanoBooster ionization coupled with high-speed digitization Qq-TOF technology and steered by intelligent acquisition software defines complex samples sharply.
Agilent Technologies introduced two applications that enhance its MassHunter Workstation software and LC/MS, GC/MS and ICP-MS instruments. These new applications empower users to create targeted screening methods for food safety and forensic analysis, and to characterize intact proteins and biosimilars for biopharmaceutical research.
Apricus Biosciences Inc. said Monday that its impotence drug Vitaros has been approved in 10 European countries. The company said Vitaros is now approved in the Netherlands, Germany, France, Italy, and the U.K., among other countries, for the treatment of erectile dysfunction. Apricus sought...
WASHINGTON--(BUSINESS WIRE)--BIO & Delaware Bio commend the State Senate for introducing legislation designed to address the regulatory issues related to the interchangeability of biological medicines.
Pall Corporation introduced the XRS 20 Bioreactor System, a new bioreactor with unique agitation properties that incorporates a single-use, easy-to-use Allegro 3-D biocontainer.
Scientists have discovered a cellular process used by animals when a tissue is stressed and in molecular trouble from the expression of misfolded and damaged proteins: The tissue at risk attends to the trouble itself but also wisely calls out for help.
Scientists have discovered genes that control shape changes in melanoma skin cancer cells, allowing them to wriggle free and spread around the body. The research could pave the way for scientists to develop drugs for malignant skin melanoma.
New research has revealed distinct sets of itch-generating neurons that explain why current itch therapies often fail and suggest new ways to selectively silence itch. One day, the very sensation that sends your fingernails scrambling over your scalp may open the door to relief.
Scientists have deciphered how a protein called Arc regulates the activity of neurons– providing much-needed clues into the brain’s ability to form long-lasting memories. These findings also offer newfound understanding as to what goes on at the molecular level when this process becomes disrupted.
What draws a mosquito to bite its host has long been studied from the perspective of the victim— uncovering which smells and chemicals lure the insect in. But researchers are aiming instead to get inside the perpetrator’s mind. Or rather, its genome.